JP2015227318A - 4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative and production method thereof - Google Patents

4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative and production method thereof Download PDF

Info

Publication number
JP2015227318A
JP2015227318A JP2014114123A JP2014114123A JP2015227318A JP 2015227318 A JP2015227318 A JP 2015227318A JP 2014114123 A JP2014114123 A JP 2014114123A JP 2014114123 A JP2014114123 A JP 2014114123A JP 2015227318 A JP2015227318 A JP 2015227318A
Authority
JP
Japan
Prior art keywords
trifluoromethyl
trifluoroethoxy
pyrimidine
pyrimidine derivative
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014114123A
Other languages
Japanese (ja)
Other versions
JP6262079B2 (en
Inventor
香川 巧
Takumi Kagawa
巧 香川
大樹 重弘
Daiki Shigehiro
大樹 重弘
恒佐 河田
Tsunesuke Kawada
恒佐 河田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosoh F Tech Inc
Original Assignee
Tosoh F Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh F Tech Inc filed Critical Tosoh F Tech Inc
Priority to JP2014114123A priority Critical patent/JP6262079B2/en
Publication of JP2015227318A publication Critical patent/JP2015227318A/en
Application granted granted Critical
Publication of JP6262079B2 publication Critical patent/JP6262079B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

PROBLEM TO BE SOLVED: To provide a 4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative useful as a pharmaceutical and agrochemical intermediate and electronic material intermediate, and to provide a production method of the pyrimidine derivative.SOLUTION: A 4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative is represented by formula (1), and a production method of the pyrimidine derivative comprises a step of synthesizing with reaction of 2,4-bis(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine, and metal alkoxide or metal phenoxide. In the formula (1), R is a methyl group, ethyl group, linear, branched or cyclic alkyl group having 3 to 6 carbon atoms, phenyl group or benzyl group.

Description

本発明は、新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法に関する。本発明の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体は各種、医農薬や電子材料の合成原料として有用な化合物である。   The present invention relates to a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and a method for producing the same. The 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention is a compound useful as a raw material for synthesizing various medical and agricultural chemicals and electronic materials.

従来より、本発明の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法は知られていない。
類似の化合物として、2−(4−ニトロフェノキシ)−4−クロロ−5−(トリフルオロメチル)ピリミジン及びその製造方法(例えば特許文献1参照)並びに2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジン及びその製造方法(例えば特許文献2参照)が知られている。
Conventionally, the 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention and the production method thereof have not been known.
As similar compounds, 2- (4-nitrophenoxy) -4-chloro-5- (trifluoromethyl) pyrimidine and its production method (see, for example, Patent Document 1) and 2-methoxy-4-chloro-5- (tri Fluoromethyl) pyrimidine and a method for producing the same (see, for example, Patent Document 2) are known.

しかしながら、特許文献1に記載の方法は、4−ニトロフェノルを用い2−(4−ニトロフェノキシ)−4−クロロ−5−(トリフルオロメチル)ピリミジンを得る方法に限られるという課題があった。
一方、特許文献2に記載の方法は、目的物の2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンと異性体の4−メトキシ−2−クロロ−5−(トリフルオロメチル)ピリミジンの混合物を得る方法であり、シリカゲルカラム精製により目的物の2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンを得ており、工業的に実施が困難なシリカゲルカラム精製が必要という課題があった。
However, the method described in Patent Document 1 has a problem that it is limited to a method of obtaining 2- (4-nitrophenoxy) -4-chloro-5- (trifluoromethyl) pyrimidine using 4-nitrophenol.
On the other hand, the method described in Patent Document 2 includes the target 2-methoxy-4-chloro-5- (trifluoromethyl) pyrimidine and the isomer 4-methoxy-2-chloro-5- (trifluoromethyl) pyrimidine. The target 2-methoxy-4-chloro-5- (trifluoromethyl) pyrimidine is obtained by silica gel column purification, and it is necessary to purify the silica gel column, which is difficult to implement industrially. was there.

さらに、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンに各種金属アルコキシド等を反応させた場合、反応させる金属アルコキシドの種類により、組成は変動するが、生成物は2−位が置換されたものと4−位が置換されたものの混合物となるという課題があった。   Furthermore, when various metal alkoxides are reacted with 2,4-dichloro-5- (trifluoromethyl) pyrimidine, the composition varies depending on the type of metal alkoxide to be reacted, but the product is substituted at the 2-position. There was a problem that it became a mixture of the one and 4-position substituted.

特表2013−501759号公報Special table 2013-501759 gazette 特表2008−528613号公報Special table 2008-528613

本発明は、2−位又は4−位が置換された5−(トリフルオロメチル)ピリミジン誘導体の合成原料として有用な、2−位が置換された4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法の提供にある。   The present invention is useful as a raw material for synthesizing 5- (trifluoromethyl) pyrimidine derivatives substituted at 2-position or 4-position, and 4- (2,2,2-trifluoroethoxy substituted at 2-position. ) -5- (trifluoromethyl) pyrimidine derivatives and methods for producing the same.

本発明者らは、2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを原料とし、金属アルコキシド又は金属フェノキシドを反応させることにより、非常の高選択的に2−位がアルコキシで置換された新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体が得られることを見出し、本発明を完成させるに至った。   The present inventors use 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine as a raw material, and react with metal alkoxide or metal phenoxide to achieve a very high selection. Thus, it was found that a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative substituted with alkoxy at the 2-position was obtained, and the present invention was completed. It was.

すなわち本発明は、下記一般式(1)   That is, the present invention provides the following general formula (1)

Figure 2015227318
Figure 2015227318

(式(1)中、Rは、メチル基、エチル基、炭素数3〜6の直鎖分岐若しくは環式のアルキル基、フェニル基又はベンジル基を示す)
で表される4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体に関するもので、下記式(2)
(In the formula (1), R represents a methyl group, an ethyl group, a linear branched or cyclic alkyl group having 3 to 6 carbon atoms, a phenyl group, or a benzyl group)
4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the following formula (2)

Figure 2015227318
Figure 2015227318

で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンと、下記一般式(3)
RO−M (3)
(式(3)中、Rは前記式(1)に同じ)
で表わされる金属アルコキシド又は金属フェノキシドを反応させ製造する方法を提供するものである。
2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine represented by the following general formula (3)
RO-M (3)
(In the formula (3), R is the same as the formula (1))
The metal alkoxide or metal phenoxide represented by these is made to react, and the manufacturing method is provided.

本発明により、医農薬の合成原料として有用な新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその高選択的製造方法が提供できる。   INDUSTRIAL APPLICABILITY According to the present invention, a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative useful as a synthetic raw material for medical and agricultural chemicals and a highly selective production method thereof can be provided.

以下、本発明を詳細に説明する。
本発明の一般式(1)で表わされる4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体としては、具体的には例えば、2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−エトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−sec−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−iso−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ペントキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−cyclo−ペントキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−cylo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン等を挙げることができる。
Hereinafter, the present invention will be described in detail.
Specific examples of the 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention include 2-methoxy-4- ( 2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-ethoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n -Propoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-iso-propoxy-4- (2,2,2-trifluoroethoxy) -5- (tri Fluoromethyl) pyrimidine, 2-n-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-sec-butoxy-4- (2, , 2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-iso-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-tert- Butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n-pentoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoro Methyl) pyrimidine, 2-cyclo-pentoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n-hexyloxy-4- (2,2,2-tri) Fluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-cylo-hexyloxy-4- (2,2,2-trifluoroethoxy) -5- ( (Rifluoromethyl) pyrimidine, 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-benzyloxy-4- (2,2,2-trifluoroethoxy) Examples include -5- (trifluoromethyl) pyrimidine.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に使用する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンは、例えば、工業的に入手可能な5−(トリフルオロメチル)ウラシルをオキシ塩化リン等より脱水及び塩素化し、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンを調製の後、さらに2,2,2−トリフルオロエタノールの金属塩を反応させること等により調製可能である。   2,4-bis (2,2,2-trifluoroethoxy) -5 represented by the formula (2) used for the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention -(Trifluoromethyl) pyrimidine is obtained by, for example, dehydrating and chlorinating commercially available 5- (trifluoromethyl) uracil from phosphorus oxychloride and the like to produce 2,4-dichloro-5- (trifluoromethyl) pyrimidine Can be prepared by reacting a metal salt of 2,2,2-trifluoroethanol.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドとしては、具体的には例えば、リチウムメトキシド、ナトリウムメトキシド、カリウムメトキシド、リチウムエトキシド、ナトリウムエトキシド、カリウムエトキシド、リチウム−n−プロポキシド、ナトリウム−n−プロポキシド、カリウム−n−プロポキシド、リチウム−iso−プロポキシド、ナトリウム−iso−プロポキシド、カリウム−iso−プロポキシド、リチウム−n−ブトキシド、ナトリウム−n−ブトキシド、カリウム−n−ブトキシド、リチウム−iso−ブトキシド、ナトリウム−iso−ブトキシド、カリウム−iso−ブトキシド、リチウム−sec−ブトキシド、ナトリウム−sec−ブトキシド、カリウム−sec−ブトキシド、リチウム−tert−ブトキシド、ナトリウム−tert−ブトキシド、カリウム−tert−ブトキシド、リチウム−n−ペントキシド、ナトリウム−n−ペントキシド、カリウム−n−ペントキシド、リチウム−n−ヘキシルオキシド、ナトリウム−n−ヘキシルオキシド、カリウム−n−ヘキシルオキシド、リチウム−cyclo−ヘキシルオキシド、ナトリウム−cyclo−ヘキシルオキシド、カリウム−cyclo−ヘキシルオキシド、リチウムフェノキシド、ナトリウムフェノキシド、カリウムフェノキシド、リチウムベンジロキシド、ナトリウムベンジロキシド、カリウムベンジロキシド等が挙げられる。   As the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention, specifically, for example, lithium methoxy Sodium methoxide, potassium methoxide, lithium ethoxide, sodium ethoxide, potassium ethoxide, lithium-n-propoxide, sodium-n-propoxide, potassium-n-propoxide, lithium-iso-propoxide, Sodium-iso-propoxide, potassium-iso-propoxide, lithium-n-butoxide, sodium-n-butoxide, potassium-n-butoxide, lithium-iso-butoxide, sodium-iso-butoxide, potassium-iso-butoxide, Lichiu -Sec-butoxide, sodium-sec-butoxide, potassium-sec-butoxide, lithium-tert-butoxide, sodium-tert-butoxide, potassium-tert-butoxide, lithium-n-pentoxide, sodium-n-pentoxide, potassium-n -Pentoxide, lithium-n-hexyl oxide, sodium-n-hexyl oxide, potassium-n-hexyl oxide, lithium-cyclo-hexyl oxide, sodium-cyclo-hexyl oxide, potassium-cyclo-hexyl oxide, lithium phenoxide, sodium phenoxide Potassium phenoxide, lithium benzyloxide, sodium benzyloxide, potassium benzyloxide and the like.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドの使用量は、反応に具する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンに対して、1.0モル倍量〜1.5モル倍量の範囲である。   The amount of the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention is determined by the formula ( 2) In the range of 1.0 mol times to 1.5 mol times the amount of 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine represented by 2) is there.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドは、市販されているものであればそのまま用いても良いし、市販されていないものは該当するアルコール類又はフェノールに、例えば、水素化リチウム、水素化ナトリウム、水素化カリウム、n−ブチルリチウム、tert−ブチルリチウム、リチウム ヘキサメチルジシラジド、ナトリウム ヘキサメチルジシラジド、カリウム ヘキサメチルジシラジド等の金属試剤を、アルコール類又はフェノールに対して0.7モル倍量〜1.0モル倍量使用し調製しても良い。   If the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention is commercially available, it is used as it is. Those that are not commercially available may be used as appropriate alcohols or phenols, for example, lithium hydride, sodium hydride, potassium hydride, n-butyl lithium, tert-butyl lithium, lithium hexamethyldisilazide. Metal reagents such as sodium hexamethyldisilazide, potassium hexamethyldisilazide, etc. may be prepared by using 0.7 mol times to 1.0 mol times the amount of alcohol or phenol.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な溶剤としては、反応に不活性な溶剤であればあらゆるものが使用可能であるが、例えば、ジエチルエーテル、ジ−iso−プロピルエーテル、メチル−tert−ブチルエーテル、メチル−cyclo−ペンチルエーテル、テトラヒドロフラン等のエーテル系溶剤、ペンタン、ヘキサン、cyclo−ヘキサン等の脂肪族炭化水素系溶剤、ベンゼン、トルエン、エチルベンゼン、キシレン、メシチレン、クメン等の芳香族炭化水素系溶剤等が挙げられ、反応に具する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンに対して、2重量倍量〜100重量倍量使用する。また、これら溶剤は2種以上を混合して用いても良い。   As the solvent applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention, any solvent can be used as long as it is inert to the reaction. Ether solvents such as diethyl ether, di-iso-propyl ether, methyl-tert-butyl ether, methyl-cyclo-pentyl ether, tetrahydrofuran, aliphatic hydrocarbon solvents such as pentane, hexane, cyclo-hexane, benzene, toluene, Examples include aromatic hydrocarbon solvents such as ethylbenzene, xylene, mesitylene, cumene, etc., and 2,4-bis (2,2,2-trifluoroethoxy) -5 represented by the formula (2) included in the reaction. 2 to 100 times the amount of (trifluoromethyl) pyrimidine is used. Moreover, you may use these solvents in mixture of 2 or more types.

本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造の反応温度及び時間としては、反応に用いる金属アルコキシドの種類、溶剤の種類及び基質濃度により異なるが、通常−20℃〜80℃の温度範囲で、1時間〜48時間反応を行うことにより反応が完結する。
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造後の後処理としては、周知の方応で実施可能で、例えば、飽和塩化アンモニウム水溶液で中和、ジクロロメタン等の溶剤で抽出、硫酸ナトリウム上で乾燥、ろ過、濃縮することにより、一般式(1)で表わされる4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体を得る。
The reaction temperature and time for producing the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention vary depending on the type of metal alkoxide used in the reaction, the type of solvent, and the substrate concentration. The reaction is completed by carrying out the reaction for 1 hour to 48 hours in a temperature range of 20 ° C to 80 ° C.
The post-treatment after the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention can be carried out by a well-known method, such as neutralization with a saturated aqueous ammonium chloride solution, dichloromethane or the like. The 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) was obtained by extraction with a solvent of the above, drying over sodium sulfate, filtration, and concentration. obtain.

以下実施例により本発明を具体的に説明するが、本発明はこれらの実施例のみに限定されるものではない。
なお、分析に当たっては下記機器を使用した。
1H−NMR,19F−NMR,13C−NMR:ブルカー社(BRUKER)製AVANCE II 400。
GC-MS:嶋津製作所製GCMS−QP2010Plus。
元素分析:ヤナコ社製CHNコーダー MT−6。
EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited only to these examples.
The following equipment was used for the analysis.
1 H-NMR, 19 F-NMR, 13 C-NMR: AVANCE II 400 manufactured by Bruker.
GC-MS: Shimadzu GCMS-QP2010Plus.
Elemental analysis: CHN coder MT-6 manufactured by Yanaco.

参考例1 2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
窒素気流下、撹拌子を備えた200mLのナス型フラスコに、2,2,2−トリフルオロエタノール(5.99g,59.9mmol)及びテトラヒドロフラン(85mL)を仕込み、−20℃に冷却の後、n−ブチルリチウム(1.6M−ヘキサン溶液,34.5mL,55.2mmol)を添加し、同温度で30分撹拌した。次いでこれに、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジン(5.00g,23.0mmol)を添加し、同温度で30分撹拌の後、昇温し、40℃で24時間反応を行った。
Reference Example 1 Preparation of 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine In a 200 mL eggplant-shaped flask equipped with a stirrer under a nitrogen stream, 2,2, 2-Trifluoroethanol (5.99 g, 59.9 mmol) and tetrahydrofuran (85 mL) were charged, cooled to −20 ° C., and then n-butyllithium (1.6 M-hexane solution, 34.5 mL, 55.2 mmol). And stirred at the same temperature for 30 minutes. Next, 2,4-dichloro-5- (trifluoromethyl) pyrimidine (5.00 g, 23.0 mmol) was added thereto, and the mixture was stirred at the same temperature for 30 minutes, then warmed and reacted at 40 ° C. for 24 hours. Went.

反応終了後、反応液に飽和の塩化アンモニウム水溶液(30mL)を添加、減圧下濃縮、ジクロロメタン(30ml×3回)抽出、硫酸ナトリウム上で乾燥、ろ過、減圧濃縮することにより粗製物を得た。
得られた粗製物は、シリカゲル床(10g、溶離液ジクロロメタン)で精製、濃縮することにより目的物の2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(7.22g,21.0mmol,収率91%)を無色透明液体として得た。
1H−NMR(CDCl3,400MHz)δ8.60(d,J=0.8Hz,1H),4.91(q,J=4.9Hz,2H),4.85(q,J=4.8Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.80,−74.82(t,J=7.5Hz),−74.89(t,J=7.5Hz)。
13C−NMR(CDCl3,100MHz)δ167.07,165.00,158.38(q,J=4.7Hz),122.99(q,J=275.8Hz),122.74(q,J=275.6Hz),122.28(q,J=269.4Hz),108.05(q,J=34.7Hz),64.39(q,J=36.7Hz),63.39(q,J=37.2Hz)。
GC−MS(m/z):344(M+,45),325(58),275(100),246(93),163(90),83(95)。
元素分析
計算値:炭素(31.41%)、水素(1.46%)、窒素(8.14%)。
測定値:炭素(31.32%)、水素(1.46%)、窒素(8.16%)。
After completion of the reaction, a saturated aqueous ammonium chloride solution (30 mL) was added to the reaction solution, concentrated under reduced pressure, extracted with dichloromethane (30 ml × 3 times), dried over sodium sulfate, filtered, and concentrated under reduced pressure to obtain a crude product.
The obtained crude product was purified by silica gel bed (10 g, eluent dichloromethane) and concentrated to give the desired 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl). Pyrimidine (7.22 g, 21.0 mmol, 91% yield) was obtained as a colorless transparent liquid.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.60 (d, J = 0.8 Hz, 1H), 4.91 (q, J = 4.9 Hz, 2H), 4.85 (q, J = 4. 8Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.80, −74.82 (t, J = 7.5 Hz), −74.89 (t, J = 7.5 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 167.07, 165.00, 158.38 (q, J = 4.7 Hz), 122.99 (q, J = 275.8 Hz), 122.74 (q, J = 275.6 Hz), 122.28 (q, J = 269.4 Hz), 108.05 (q, J = 34.7 Hz), 64.39 (q, J = 36.7 Hz), 63.39 ( q, J = 37.2 Hz).
GC-MS (m / z): 344 (M + , 45), 325 (58), 275 (100), 246 (93), 163 (90), 83 (95).
Elemental analysis calculated: carbon (31.41%), hydrogen (1.46%), nitrogen (8.14%).
Measurements: carbon (31.32%), hydrogen (1.46%), nitrogen (8.16%).

実施例1 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(4)の調製   Example 1 Preparation of 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (4)

Figure 2015227318
Figure 2015227318

撹拌子を備え、窒素置換した50mLのナス型フラスコに、ベンジルアルコール(0.310g,2.91mmol)及びテトラヒドロフラン(20mL)を仕込み、−20℃に冷却の後、n−ブチルリチウム(1.6M−ヘキサン溶液,1.82mL,2.91mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で30分撹拌の後、室温に戻し、12時間反応を行った。反応終了後、飽和塩化アンモニウム水溶液(10mL)を添加、減圧濃縮によりテトラヒロロフランを留去、ジクロロメタン(10mL×3回)抽出、有機層を合わせて、硫酸ナトリウム上で乾燥、ろ過、次いで濃縮することにより、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.21g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率95%、収率92%で、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.2%含有されていた。 Benzyl alcohol (0.310 g, 2.91 mmol) and tetrahydrofuran (20 mL) were charged into a 50 mL eggplant type flask equipped with a stir bar and purged with nitrogen. After cooling to −20 ° C., n-butyllithium (1.6 M -Hexane solution, 1.82 mL, 2.91 mmol) was added, and the mixture was stirred at the same temperature for 30 minutes. Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 30 at the same temperature. After stirring for a minute, the temperature was returned to room temperature and the reaction was carried out for 12 hours. After completion of the reaction, a saturated aqueous solution of ammonium chloride (10 mL) is added. Tetrachlorofuran is distilled off by concentration under reduced pressure, extraction with dichloromethane (10 mL × 3 times), the organic layers are combined, dried over sodium sulfate, filtered, and concentrated. This gave crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine as a slightly pale yellow solid (1.21 g). In 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into 95% by 92% yield and by-product 2- (2,2,2-trifluoroethoxy). -4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.2% in terms of yield.

さらに得られた粗製物を、エチルベンゼン−ヘキサンを用いた再結晶を行うことにより、精製2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを白色固体として得た(0.77g,収率75%、純度99%)。
1H−NMR(CDCl3,400MHz)δ8.58(d,J=0.8Hz,1H),7.47−7.35(m,5H),5.47(s,2H),4.85(q,J=8.0Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.71,−75.03(t,J=7.5Hz)。
13C−NMR(CDCl3,100MHz)δ166.58,166.28,158.45(q,J=4.7Hz),135.52,128.84,128.73,128.40,122.82(q,J=275.2Hz),122.58(q,J=269.2Hz),106.49(q,J=34.5Hz),70.60,63.01(q,J=37.0Hz)。
GC−MS(m/z)352(10,M+),351(8),269(7),246(35),107(6),91(100),65(21)。
元素分析
計算値:炭素(47.74%)、水素(2.86%)、窒素(7.95%)。
測定値:炭素(47.62%)、水素(2.87%)、窒素(7.93%)。
Further, the obtained crude product was recrystallized from ethylbenzene-hexane to obtain purified 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine in white. Obtained as a solid (0.77 g, 75% yield, 99% purity).
1 H-NMR (CDCl 3 , 400 MHz) δ 8.58 (d, J = 0.8 Hz, 1H), 7.47-7.35 (m, 5H), 5.47 (s, 2H), 4.85 (Q, J = 8.0 Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.71, −75.03 (t, J = 7.5 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.58, 166.28, 158.45 (q, J = 4.7 Hz), 135.52, 128.84, 128.73, 128.40, 122.82 (Q, J = 275.2 Hz), 122.58 (q, J = 269.2 Hz), 106.49 (q, J = 34.5 Hz), 70.60, 63.01 (q, J = 37. 0 Hz).
GC-MS (m / z) 352 (10, M + ), 351 (8), 269 (7), 246 (35), 107 (6), 91 (100), 65 (21).
Elemental analysis calculated: carbon (47.74%), hydrogen (2.86%), nitrogen (7.95%).
Measurements: carbon (47.62%), hydrogen (2.87%), nitrogen (7.93%).

実施例2 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
実施例1と同じ反応装置に、水素化ナトリウム(60%油性、0.163g,4.07mmol)及びテトラヒドロフラン(40mL)を仕込み、0℃に冷却の後、ベンジルアルコール(0.450g,4.22mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で24時間反応を行った。反応収率後、実施例1と同じ後処理操作を行い、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.27g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率100%、収率96%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.5%含有されていた。
Example 2 Preparation of 2-Benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine In the same reactor as in Example 1, sodium hydride (60% oily, 0. 163 g, 4.07 mmol) and tetrahydrofuran (40 mL) were charged, and after cooling to 0 ° C., benzyl alcohol (0.450 g, 4.22 mmol) was added and stirred at the same temperature for 30 minutes. Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 24 hours at the same temperature. Time reaction was performed. After the reaction yield, the same post-treatment operation as in Example 1 was carried out, and crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a slightly pale yellow solid. (1.27 g). The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 100%, the yield was 96%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.5% in terms of yield.

実施例3 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
実施例1と同じ反応装置に、ベンジルアルコール(0.403g,3.78mmol)及びテトラヒドロフラン(10mL)を仕込み、−10℃に冷却の後、カリウム ヘキサメチルジシラジド(1.0M−テトラヒドロフラン溶液、3.06mL,3.06mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で24時間反応を行った。反応収率後、実施例1と同じ後処理操作を行い、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.19g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率99%、収率95%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.8%含有されていた。
Example 3 Preparation of 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine To the same reactor as in Example 1, benzyl alcohol (0.403 g, 3.78 mmol) was prepared. ) And tetrahydrofuran (10 mL), and after cooling to −10 ° C., potassium hexamethyldisilazide (1.0 M-tetrahydrofuran solution, 3.06 mL, 3.06 mmol) was added and stirred at the same temperature for 30 minutes. . Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 24 hours at the same temperature. Time reaction was performed. After the reaction yield, the same post-treatment operation as in Example 1 was carried out, and crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a slightly pale yellow solid. (1.19 g). The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 99%, the yield was 95%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.8% in terms of yield.

実施例4 2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(5)の調製   Example 4 Preparation of 2-methoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (5)

Figure 2015227318
Figure 2015227318

実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてメタノール(0.092g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.82g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率92%、収率89%で、副生物の2−(2,2,2−トリフルオロエトキシ)−4−メトキシ−5−(トリフルロメチル)ピリミジンが収率換算で2.3%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.58(d,J=0.8Hz,1H),4.90(q,J=8.1Hz,2H),4.08(s,3H)。
19F−NMR(CDCl3,376MHz)δ−63.60,−74.94(t,J=8.1Hz)。
13C−NMR(CDCl3,100MHz)δ166.93,166.54,158.49(q,J=4.7Hz),122.86(q,J=275.6Hz),122.63(q,J=268.9Hz),106.25(q,J=34.5Hz),62.88(q,J=37.1Hz),55.86。
GC−MS m/z276(49,M+),275(27),257(24),246(100),163(37),143(32),91(27),83(23),69(21)。
元素分析
計算値:炭素(34.80%)、水素(2.19%)、窒素(10.14%)。
測定値:炭素(34.71%)、水素(2.19%)、窒素(10.13%)。
The same operation as in Example 1 was carried out except that methanol (0.092 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-methoxy-4- (2 , 2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (0.82 g) was obtained as a colorless transparent liquid. In the 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into a by-product 2- (2,2,2-trifluoroethoxy) with a conversion rate of 92% and a yield of 89%. -4-Methoxy-5- (trifluoromethyl) pyrimidine was contained 2.3% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.58 (d, J = 0.8 Hz, 1H), 4.90 (q, J = 8.1 Hz, 2H), 4.08 (s, 3H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.60, −74.94 (t, J = 8.1 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.93, 166.54, 158.49 (q, J = 4.7 Hz), 122.86 (q, J = 275.6 Hz), 122.63 (q, J = 268.9 Hz), 106.25 (q, J = 34.5 Hz), 62.88 (q, J = 37.1 Hz), 55.86.
GC-MS m / z 276 (49, M + ), 275 (27), 257 (24), 246 (100), 163 (37), 143 (32), 91 (27), 83 (23), 69 ( 21).
Elemental analysis calculated: carbon (34.80%), hydrogen (2.19%), nitrogen (10.14%).
Measurements: carbon (34.71%), hydrogen (2.19%), nitrogen (10.13%).

実施例5 2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(6)の調製   Example 5 Preparation of 2-iso-propoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (6)

Figure 2015227318
Figure 2015227318

実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてiso−プロパノール(0.175g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.98g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率96%、収率94%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−iso−プロポキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.3%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.55(d,J=0.8Hz,1H),5.35(dq,J=6.4,6.3Hz,1H),4.90(q,J=8.1Hz,2H),1.42(d,J=6.4Hz,6H)。
19F−NMR(CDCl3,376MHz)δ−63.30,−74.82(t,J=9.4Hz)。
13C−NMR(CDCl3,100MHz)δ166.52,166.11,158.43(q,J=4.7Hz),122.89(q,J=275.7Hz),122.69(q,J=268.7Hz),105.83(q,J=34.0Hz),72.58,62.89(q,J=37.0Hz),21.75。
GC−MS(m/z)304(2,M+),289(12),263(94),246(100),243(27),223(16),193(35),164(28),136(33),83(23)。
元素分析
計算値:炭素(39.48%)、水素(3.31%)、窒素(9.21%)。
測定値:炭素(39.42%)、水素(3.31%)、窒素(9.19%)。
The same procedure as in Example 1 was performed except that iso-propanol (0.175 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-iso-propoxy- A crude product (0.98 g) of 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a colorless transparent liquid. The obtained crude product was subjected to a 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 96%, the yield was 94%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-iso-propoxy-5- (trifluoromethyl) pyrimidine contained 1.3% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.55 (d, J = 0.8 Hz, 1H), 5.35 (dq, J = 6.4, 6.3 Hz, 1H), 4.90 (q, J = 8.1 Hz, 2H), 1.42 (d, J = 6.4 Hz, 6H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.30, −74.82 (t, J = 9.4 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.52, 166.11, 158.43 (q, J = 4.7 Hz), 122.89 (q, J = 275.7 Hz), 122.69 (q, J = 268.7 Hz), 105.83 (q, J = 34.0 Hz), 72.58, 62.89 (q, J = 37.0 Hz), 21.75.
GC-MS (m / z) 304 (2, M + ), 289 (12), 263 (94), 246 (100), 243 (27), 223 (16), 193 (35), 164 (28) 136 (33), 83 (23).
Elemental analysis calculated: carbon (39.48%), hydrogen (3.31%), nitrogen (9.21%).
Measurements: carbon (39.42%), hydrogen (3.31%), nitrogen (9.19%).

実施例6 2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(7)の調製   Example 6 Preparation of 2-tert-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (7)

Figure 2015227318
Figure 2015227318

実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてtert−ブタノール(0.216g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.94g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率93%、収率93%、副生物の2−(トリフルオロエトキシ)−4−tert−ブトキシ−5−(トリフルロメチル)ピリミジンは観測されなかった。
1H−NMR(CDCl3,400MHz)δ8.54(d,J=0.8Hz,1H),4.85(q,J=8.1Hz,2H),1.66(s,9H)。
19F−NMR(CDCl3,376MHz)δ−63.70,−74.87(t,J=9.4Hz)。
13C−NMR(CDCl3,100MHz)δ166.12(d,J=1.3Hz),165.96,158.06(q,J=4.7Hz),122.91(q,J=275.5Hz),122.79(q,J=268.7Hz),105.51(q,J=34.5Hz),69.03,62.98(q,J=36.9Hz),28.30。
GC−MS(m/z)303(4),263(91),243(15),223(8),83(9),57(100)。
The same operation as in Example 1 was performed except that tert-butanol (0.216 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-tert-butoxy- A crude product (0.94 g) of 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 93%, the yield was 93%, and the by-product 2- (trifluoroethoxy) -4-tert-butoxy- 5- (Trifluoromethyl) pyrimidine was not observed.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.54 (d, J = 0.8 Hz, 1H), 4.85 (q, J = 8.1 Hz, 2H), 1.66 (s, 9H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.70, −74.87 (t, J = 9.4 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.12 (d, J = 1.3 Hz), 165.96, 158.06 (q, J = 4.7 Hz), 122.91 (q, J = 275. 5 Hz), 122.79 (q, J = 268.7 Hz), 105.51 (q, J = 34.5 Hz), 69.03, 62.98 (q, J = 36.9 Hz), 28.30.
GC-MS (m / z) 303 (4), 263 (91), 243 (15), 223 (8), 83 (9), 57 (100).

実施例7 2−cyclo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(8)の調製   Example 7 Preparation of 2-cyclo-hexyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (8)

Figure 2015227318
Figure 2015227318

実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてcyclo−ヘキサノール(0.291g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−cyclo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(1.25g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率97%、収率96%、副生物の2−(トリフルオロエトキシ)−4−cyclo−ヘキシルオキシ−5−(トリフルロメチル)ピリミジンが収率換算で0.7%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.54(d,J=0.8Hz,1H),5.12−5.02(m,1H),4.87(q,J=8.1Hz,2H),2.07−1.27(m,10H)。
19F−NMR(CDCl3,376MHz)δ−63.55,−74.99(t,J=8.1Hz)。
13C−NMR(CDCl3,100MHz)δ166.53,166.12,158.38(q,J=4.7Hz),122.89(q,J=275.7Hz),122.69(q,J=268.9Hz),105.79(q,J=34.4Hz),77.55,62.90(q,J=37.0Hz),31.62,25.49,23.98。
GC−MS(m/z)263(100),247(21),246(20),243(16),223(7),83(22%)。
元素分析
計算値:炭素(45.36%)、水素(4.10%)、窒素(8.14%)。
測定値:炭素(45.31%)、水素(4.11%)、窒素(8.12%)。
The same operation as in Example 1 was carried out except that cyclohexanol (0.291 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-cyclo-hexyloxy was used. A crude product of -4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.25 g) was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 97%, the yield was 96%, and the by-product 2- (trifluoroethoxy) -4-cyclo-hexyloxy was obtained. -5- (Trifluoromethyl) pyrimidine contained 0.7% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.54 (d, J = 0.8 Hz, 1H), 5.12-5.02 (m, 1H), 4.87 (q, J = 8.1 Hz, 2H), 2.07-1.27 (m, 10H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.55, −74.99 (t, J = 8.1 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.53, 166.12, 158.38 (q, J = 4.7 Hz), 122.89 (q, J = 275.7 Hz), 122.69 (q, J = 268.9 Hz), 105.79 (q, J = 34.4 Hz), 77.55, 62.90 (q, J = 37.0 Hz), 31.62, 25.49, 23.98.
GC-MS (m / z) 263 (100), 247 (21), 246 (20), 243 (16), 223 (7), 83 (22%).
Elemental analysis calculated: carbon (45.36%), hydrogen (4.10%), nitrogen (8.14%).
Measurements: carbon (45.31%), hydrogen (4.11%), nitrogen (8.12%).

実施例8 2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(9)の調製   Example 8 Preparation of 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (9)

Figure 2015227318
Figure 2015227318

実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてフェノール(0.274g,2.91mmol)を用い、60℃で36時間反応を行った以外、実施例1と同じ操作を行い、2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(1.18g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率65%、収率58%、副生物の2−(トリフルオロエトキシ)−4−フェノキシ−5−(トリフルロメチル)ピリミジンが収率換算で0.5%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.56(d,J=0.4Hz,1H),7.47−6.46(m,5H),4.92(q,J=8.1Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.27,−74.75(t,J=7.5Hz)。
GC−MS(m/z)338(60,M+),319(16),269(11),246(38),192(15),104(20),93(100),77(87%)。
The same operation as in Example 1 was performed except that phenol (0.274 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1 and the reaction was performed at 60 ° C. for 36 hours. , 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine crude product (1.18 g) was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard, and the conversion was 65%, the yield was 58%, and the by-product 2- (trifluoroethoxy) -4-phenoxy-5- (Trifluoromethyl) pyrimidine contained 0.5% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.56 (d, J = 0.4 Hz, 1H), 7.47-6.46 (m, 5H), 4.92 (q, J = 8.1 Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.27, −74.75 (t, J = 7.5 Hz).
GC-MS (m / z) 338 (60, M + ), 319 (16), 269 (11), 246 (38), 192 (15), 104 (20), 93 (100), 77 (87% ).

比較例1 2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンとリチウム ベンジロキシドの反応
実施例1と同じ反応装置を用い、2,4−ビス(2,2,2−トリクロロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)に替えて2,4−ジクロロ−5−(トリフルオロメチル)ピリミジン(0.63g,2.91mmol)を用い、0℃で6時間反応を行った以外は実施例1と同じ操作を行い、粗製物(0.86g)を得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率95%で2−ベンジロキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンが収率換算で57%、2−クロロ−5−ベンジロキシ−5−(トリフルオロメチル)ピリミジンが収率換算で35%含有される混合物であった。
Comparative Example 1 Reaction of 2,4-dichloro-5- (trifluoromethyl) pyrimidine and lithium benzyloxide Using the same reaction apparatus as in Example 1, 2,4-bis (2,2,2-trichloroethoxy) -5 (Trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) was used instead of 2,4-dichloro-5- (trifluoromethyl) pyrimidine (0.63 g, 2.91 mmol), and the reaction was performed at 0 ° C. for 6 hours. The same operation as in Example 1 was carried out except that the crude product (0.86 g) was obtained. In 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into 2-benzyloxy-4-chloro-5- (trifluoromethyl) pyrimidine at a conversion rate of 95% in a yield conversion of 57%. %, 2-chloro-5-benzyloxy-5- (trifluoromethyl) pyrimidine was a mixture containing 35% in terms of yield.

本発明の新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体は、各種医薬品の合成中間体として利用可能であり、5−(トリフルオロメチル)ピリミジン骨格の導入剤として期待される。   The novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention can be used as a synthetic intermediate for various pharmaceuticals, and 5- (trifluoromethyl) pyrimidine Expected to be a skeleton introduction agent.

Claims (3)

下記一般式(1)
Figure 2015227318
(式(1)中、Rは、メチル基、エチル基、炭素数3〜6の直鎖分岐若しくは環式のアルキル基、フェニル基又はベンジル基を示す)
で表される4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体。
The following general formula (1)
Figure 2015227318
(In the formula (1), R represents a methyl group, an ethyl group, a linear branched or cyclic alkyl group having 3 to 6 carbon atoms, a phenyl group, or a benzyl group)
A 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by:
下記式(2)
Figure 2015227318
で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンと、下記一般式(3)
RO−M (3)
(式(3)中、Rは前記式(1)に同じ)
で表わされる金属アルコキシド又は金属フェノキシドとを反応させることを特徴とする請求項1に記載の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体の製造方法。
Following formula (2)
Figure 2015227318
2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine represented by the following general formula (3)
RO-M (3)
(In the formula (3), R is the same as the formula (1))
The method for producing a 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative according to claim 1, wherein the metal alkoxide or metal phenoxide represented by the formula is reacted.
金属がリチウム、ナトリウム又はカリウムであることを特徴とする請求項2に記載の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体の製造方法。 The method for producing a 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative according to claim 2, wherein the metal is lithium, sodium or potassium.
JP2014114123A 2014-06-02 2014-06-02 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same Active JP6262079B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014114123A JP6262079B2 (en) 2014-06-02 2014-06-02 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014114123A JP6262079B2 (en) 2014-06-02 2014-06-02 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JP2015227318A true JP2015227318A (en) 2015-12-17
JP6262079B2 JP6262079B2 (en) 2018-01-17

Family

ID=54885034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014114123A Active JP6262079B2 (en) 2014-06-02 2014-06-02 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JP6262079B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
JP2011515372A (en) * 2008-03-20 2011-05-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Regioselective process for the preparation of substituted pyrimidines
JP2013501759A (en) * 2009-08-14 2013-01-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
JP2013545741A (en) * 2010-11-10 2013-12-26 エフ.ホフマン−ラ ロシュ アーゲー Pyrazole aminopyrimidine derivatives as LRRK2 modulators

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
JP2011515372A (en) * 2008-03-20 2011-05-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Regioselective process for the preparation of substituted pyrimidines
JP2013501759A (en) * 2009-08-14 2013-01-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
JP2013545741A (en) * 2010-11-10 2013-12-26 エフ.ホフマン−ラ ロシュ アーゲー Pyrazole aminopyrimidine derivatives as LRRK2 modulators

Also Published As

Publication number Publication date
JP6262079B2 (en) 2018-01-17

Similar Documents

Publication Publication Date Title
JP6694990B2 (en) 5- (Trifluoromethyl) pyrimidine derivative and method for producing the same
KR101728443B1 (en) Method for Producing Benzyl Ester 2-aminonicotinicotinate Derivative
KR20120117831A (en) Method for producing 2-amino-4-(trifluoromethyl)pyridine
JP6262079B2 (en) 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same
US8729320B2 (en) Method for producing difluorocyclopropane compound
JPWO2015098717A1 (en) Process for producing nitro compounds
JP5448572B2 (en) Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound
JP6431294B2 (en) 5- (Trifluoromethyl) pyrimidine derivative and process for producing the same
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
JP6797268B2 (en) A novel hydroxyphenylboronic acid ester and its production method, and a method for producing a hydroxybiphenyl compound
EP3145904A1 (en) Improved process for preparing substituted crotonic acids
KR100968576B1 (en) Process of preparing 2-acyl-3-amino-2-alkenoate
JP4968066B2 (en) Process for producing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde
JP4393839B2 (en) Preparation of 1,3-di-halo substituted benzene derivatives
JP6353772B2 (en) 2-alkoxy-5- (trifluoromethyl) pyrimidine derivative and method for producing the same
KR101548886B1 (en) Method for preparing (r)-rolipram precursor by catalytic enantioselective micahel reaction and method for preparing (r)-rolptram using the (r)-rolipram precursor
JP2016199489A (en) Method for producing 2-amino-6-methylnicotinic acid ester
KR101478597B1 (en) Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol
TW201821400A (en) Method for manufacturing nitrogen-containing compound
JP2009149591A (en) Process for preparing fluoroalkyl alcohol
JPWO2007086559A1 (en) Method for producing tetrahydropyran compound
JP2019135225A (en) Iodination of aromatic ring by hydrochloric acid solution of monochloroiodine
JP2008266183A (en) Method for producing 3,4-dialkoxy-2-(alkylthio)phenol
JPWO2005061478A1 (en) Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
JP2008247835A (en) METHOD FOR PRODUCING METHOXY GROUP-CONTAINING beta-DIKETONE COMPOUND

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170404

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20170404

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20170404

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20171109

TRDD Decision of grant or rejection written
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171130

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171206

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171213

R150 Certificate of patent or registration of utility model

Ref document number: 6262079

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250